Reviva Pharmaceuticals Holdings Inc (RVPH)

Finanzdaten der Reviva Pharmaceuticals Holdings Inc-Aktie (RVPH)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	17.64% 7.9221	9.6193	11.56	11.34	6.9847
Interest Income/Expense	0.00349	-	0.0059	0.0128	0.00766
Operating Income/Loss	17.64% -7.9221	-9.6193	-11.56	-11.34	-6.9847
Nonoperating Income/Loss	91.10% 0.4959	0.2595	0.2301	-0.3659	0.136
Income/Loss From Continuing Operations Before Tax	23.67% -7.4262	-9.729	-10.48	-12.44	-6.5996
Income Tax Expense/Benefit	261.41% 0.0074	-0.00458	0.0121	0.00644	0.00298
Income/Loss From Continuing Operations After Tax	20.54% -7.4336	-9.3553	-11.35	-11.71	-6.8517
Net Income/Loss	20.54% -7.4336	-9.3553	-11.35	-11.71	-6.8517
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,822% 29.89	1.0228	24.03	22.43	21.83
Basic Earnings Per Share	24.24% -0.25	-0.33	-0.48	-0.52	-0.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-